Mass Tort brief
Bellwether Verdicts and State Suits Escalate Mass Tort Exposure
Juries award major damages in medical device trials while state attorneys general launch new enforcement actions against cosmetics makers.
Mass Tort
Arizona filed the first state enforcement suit against L'Oréal over hair relaxer cancer risks — government lawsuits escalate legal exposure beyond civil MDL claims.
BackgroundStudies published in recent years linked chemical hair relaxers containing endocrine-disrupting compounds to higher rates of uterine and ovarian cancer. Cosmetic companies face expanding civil litigation and regulatory actions nationwide.
- State Attorney General Kris Mayes accused L'Oréal of deceptive trade practices and failing to warn consumers, threatening substantial statutory penalties.
- The lawsuit seeks civil financial penalties, consumer restitution, and mandatory health warning labels, which could reshape product marketing across the beauty sector.
- The state enforcement action operates independently from the federal hair relaxer MDL in Illinois, creating dual legal fronts for defense teams.
Mass Tort
Bayer's $7.25B Roundup settlement reached a Missouri fairness hearing — court approval is critical for capping long-standing glyphosate injury litigation liabilities.
BackgroundBayer acquired Monsanto in 2018 and inherited massive litigation over claims that glyphosate-based Roundup weedkiller causes non-Hodgkin lymphoma. Bayer has sought long-term class settlement structures to cap future legal liability.
- Circuit Judge Boyer held arguments evaluating settlement fund allocation terms for injured claimants, weighing objections from opt-out attorneys.
- Active federal claims in the Roundup MDL stand at nearly 4,000 following the June opt-out deadline, defining the scope of remaining trial risk.
- Bayer investors are monitoring the approval hearing to confirm resolution of remaining legal reserves, seeking clarity after years of litigation drag.
Mass Tort
A $40M verdict against Bard for fractured chemo ports sets strong plaintiff leverage — Becton Dickinson faces growing pressure to settle 4,000 pending device lawsuits.
BackgroundImplanted port catheters are placed beneath the skin to deliver chemotherapy and medications directly into blood vessels. Nearly 4,000 personal injury lawsuits are consolidated in federal multi-district litigation alleging the devices fracture inside patients.
- The plaintiff suffered two heart attacks after her catheter fractured and migrated into her heart chamber, prompting severe surgical complications.
- Parent company Becton Dickinson faces three additional bellwether trials scheduled through early 2027, which will test corporate liability across varying injury profiles.
- Plaintiffs' attorneys noted the $40 million award builds heavy settlement pressure across thousands of pending claims, raising the probability of a global payout.
Mass Tort
Womble Bond poached a 15-lawyer defense team to expand mass tort capabilities — law firms are investing heavily to capture booming corporate defense demand.
BackgroundCorporate law firms are expanding defense litigation practices as multi-district litigation filings hit historic highs across U.S. federal courts. Defending large-scale mass torts requires specialized trial teams.
- Partner Paul Efstratis leads the 15-lawyer group joining Womble Bond's product liability practice, expanding the firm's West Coast trial reach.
- The team specializes in consumer warranty disputes and complex product liability defense litigation, serving major corporate manufacturing clients.
- Industry analysts noted firm lateral hires reflect strong corporate spending on mass tort legal defense as corporate exposure to class litigation climbs.
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
